参考文献/References:
[1]Babjuk M,Burger M,Capoun O,et al.European Association of Urology Guidelines on Nonmuscleinvasive Bladder Cancer (Ta,T1,and Carcinoma in Situ).Eur Urol,2021 Sep 9:S0302-2838(21)01978-3.Online ahead of print.
[2]Bryan RT,Collins SI,Daykin MC,et al.Mechanisms of recurrence of Ta/T1 bladder cancer.Ann R Coll Surg Engl,2010,92(6):519-524.
[3]李佳朔,尚攀峰.经尿道膀胱肿瘤整体剜除术治疗非肌层浸润性膀胱癌的研究进展.中国微创外科杂志,2020,20(9):848-852.
[4]Kramer MW,Wolters M,Cash H,et al.Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer:update 2014.World J Urol,2015,33(4):571-579.
[5]桂俊卿,张超,徐跃文,等.膀胱微环境与膀胱癌腔内种植的关系.现代泌尿生殖肿瘤杂志,2011,3(4):226-229.
[6]Ray ER,O’Brien TS.Should urologists be spending more time on the golf course?BJU Int,2007,100(4):728-729.
[7]Tohme S,Simmons RL,Tsung A.Surgery for cancer:a trigger for metastases.Cancer Res,2017,77(7):1548-1552.
[8]Raa ST,Oosterling SJ,van der Kaaij NP,et al.Surgery promotes implantation of disseminated tumor cells,but does not increase growth of tumor cell clusters.J Surg Oncol,2005,92(2):124-129.
[9]Alieva M,van Rheenen J,Broekman MLD.Potential impact of invasive surgical procedures on primary tumor growth and metastasis.Clin Exp Metastasis,2018,35(4):319-331.
[10]Teoh JY,MacLennan S,Chan VW,et al.An international collaborative consensus statement on en bloc resection of bladder tumour incorporating two systematic reviews,a tworound delphi survey,and a consensus meeting.Eur Urol,2020,78(4):546-569.
[11]Kramer MW,Altieri V,Hurle R,et al.Current evidence of transurethral enbloc resection of nonmuscle invasive bladder cancer.Eur Urol Focus,2017,3(6):567-576.
[12]王敏捷,王尉,胡卫列,等.经尿道等离子膀胱肿瘤切除术中经膀胱黏膜下注射吉西他滨治疗非前壁的非肌层浸润性膀胱癌.中国微创外科杂志,2016,16(8):689-693.